Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Teralys Capital

Founders Jacques Bernier

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$140M
Portfolio companies 4
Rounds per year 0.31
Lead investments 0
Exits 1
Key employees Soon

Areas of investment

  • Therapeutics
  • Biotechnology
  • Medical
  • Innovation Management
  • Transportation
Summary

Teralys Capital appeared to be the Corporate Investor, which was created in 2009. The venture was found in North America in Canada. The leading representative office of defined Corporate Investor is situated in the Montru00e9al.

The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Teralys Capital, startups are often financed by iNovia Capital, Real Ventures, Revolution. The meaningful sponsors for the fund in investment in the same round are iNovia Capital, Real Ventures, Plaza Ventures. In the next rounds fund is usually obtained by iNovia Capital, Wells Fargo Capital Finance, Scotiabank.

This organization was formed by Jacques Bernier.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. The fund has exact preference in some founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Verafin, Busbud, Busbud We can highlight the next thriving fund investment areas, such as Enterprise Software, Medical. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Opposing the other organizations, this Teralys Capital works on 4 percentage points more the average amount of lead investments. The common things for fund are deals in the range of more than 100 millions dollars. The increased amount of exits for fund were in 2017. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Teralys Capital:
There are no funds here. If we find new data, we will add it here.
Typical Co-investors
Teralys Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Teralys Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AIG Horizon Partners California, San Francisco, United States
Alexa Next Stage, powered by Techstars -
Baozou Information China, Shanghai
Capital Sports Ventures Arlington, United States, Virginia
Chengpu Touzi Beijing, Beijing, China
Common Ocean Ventures New York, New York, United States
DP World Group Dubai, United Arab Emirates
Elior Group France, Ile-de-France, La Défense
Fuse Capital California, Palo Alto, United States
imec.xpand Belgium, Leuven, Vlaams-Brabant
MXC Exchange Central, Central Region, Singapore
newn Japan, Tokyo
Nomura Chiyoda, Japan
Noname Ventures California, Santa Monica, United States
OCI Bio Investments -
Oktogon Ventures Budapest, Hungary
SBA Group of Companies Lithuania, Vilniaus Apskritis, Vilnius
Swansea Innovation -
Yorktown New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Busbud

Apps
Software
Transportation
Travel
$11M30 Jan 2018 Montreal, Quebec, Canada

Zymeworks

Biotechnology
Medical
Therapeutics
$61M08 Jan 2016 Vancouver, British Columbia, Canada
News
Turnstone Biologics Raises $80 Million Series D Financing

– Turnstone Biologics Corp. announced the successful completion of an $80m Series D financing co-led by PFM Health Sciences and Point72.
– New investors include Eventide Asset Management, Surveyor Capital (a Citadel company), Ridgeback Capital Investments, Takeda Ventures, CaaS Capital, JM Family Enterprises, Inc., Northleaf Capital Partners, 404 Bio and an undisclosed investor.
– The round was joined by existing investors Versant Ventures, OrbiMed, F-Prime Capital, Sectoral Asset Management, Sixty Degree Capital, Brace Pharma Capital and Teralys Capital.
– Proceeds from the financing will be used to advance Turnstone’s pipeline of programs from its oncolytic virus and TIL therapy platforms.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Teralys Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 140M
Rounds per year 0.31
Peak activity year 2016
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Busbud

Apps
Software
Transportation
Travel
$11M30 Jan 2018 Montreal, Quebec, Canada

Zymeworks

Biotechnology
Medical
Therapeutics
$61M08 Jan 2016 Vancouver, British Columbia, Canada
Crunchbase icon

Content report

The following text will be sent to our editors: